Anyone stricken with any STD can tell you that the experience is trash. One of the most trash STD’s in existence would have to be herpes. It is a lifetime thing and there is no cure. However, The Institute of Cancer Research has found that a form of herpes is useful in the treatment of patients with skin cancer.
Scientists found that using a modified form of the Herpes Simplex I virus called T-Vec as beneficial for patients suffering from melanoma. Scientists have made it to phase III of clinical trials with V-Tec (produced by Amgen), so that means that the treatment just needs approval from the FDA to be used medically.
According to The Washington Post, this is how T-Vec works:
It starts with the herpes virus, which is magnificent at proliferating itself within cells and then causing them to burst (that’s where the cold sores come from). But T-VEC has had two key genes removed. These keep it from replicating within healthy cells, which can quickly spot it because of the missing genes.
But cancer cells aren’t as savvy, and T-VEC has its run of them. Meanwhile, T-VEC has also been modified to produce a molecule called GM-CSF, which serves as a red flag waved at the immune system.
So in addition to the destructive power of the T-VEC cells themselves, the therapy summons the immune system right to where it’s needed — the tumor.
“This is a first in class agent, a brand new therapy,” said Professor of Biological Cancer Therapies at The Institute of Cancer Research Kevin Harrington . “But it’s just the farthest along of what we hope will be many more.”